SUN-LB056 The Pharmacological Blockade of the Splicing Factor SF3B1 Exerts Antitumor Actions in Different Endocrine-Related Cancers

The intrinsic heterogeneity of endocrine-related cancers (ERCs) hampers the identification and development of global and effective therapeutic treatments for these pathologies. However, the dysregulation of the splicing process has been postulated as a new common hallmark shared by most cancer types...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Gahete, Manuel, Jiménez-Vacas, Juan, Lopez-Canovas, Juan, Vazquez-Borrego, Mari, Pedraza-Arevalo, Sergio, del Río-Moreno, Mercedes, Herrero-Aguayo, Vicente, Saez-Martinez, Prudencio, Montero-Hidalgo, Antonio, Blazquez-Encinas, Ricardo, Lara-Lopez, Araceli, Pérez-Gómez, Jesus, Gomez-Gomez, Enrique, Herrera-Martínez, Aura, Soto-Moreno, Alfonso, Castano, Justo, Luque, Raul
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2019
Soggetti:
Tumor Biology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552932/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB056
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi